vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and TEREX CORP (TEX). Click either name above to swap in a different company.

TEREX CORP is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× Alignment Healthcare, Inc.). TEREX CORP runs the higher net margin — 4.8% vs -1.1%, a 5.9% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 6.2%). TEREX CORP produced more free cash flow last quarter ($171.0M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 1.0%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Terex Corporation is an American company and worldwide manufacturer of materials processing machinery, waste and recycling equipment, mobile elevating work platforms, and equipment for the electric utility industry. Terex does business in the Americas, Europe, Australia and Asia Pacific.

ALHC vs TEX — Head-to-Head

Bigger by revenue
TEX
TEX
1.3× larger
TEX
$1.3B
$1.0B
ALHC
Growing faster (revenue YoY)
ALHC
ALHC
+38.2% gap
ALHC
44.4%
6.2%
TEX
Higher net margin
TEX
TEX
5.9% more per $
TEX
4.8%
-1.1%
ALHC
More free cash flow
TEX
TEX
$226.4M more FCF
TEX
$171.0M
$-55.4M
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
1.0%
TEX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALHC
ALHC
TEX
TEX
Revenue
$1.0B
$1.3B
Net Profit
$-11.0M
$63.0M
Gross Margin
18.8%
Operating Margin
-1.0%
10.4%
Net Margin
-1.1%
4.8%
Revenue YoY
44.4%
6.2%
Net Profit YoY
64.6%
2963.6%
EPS (diluted)
$-0.04
$0.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
TEX
TEX
Q4 25
$1.0B
$1.3B
Q3 25
$993.7M
$1.4B
Q2 25
$1.0B
$1.5B
Q1 25
$926.9M
$1.2B
Q4 24
$701.2M
$1.2B
Q3 24
$692.4M
$1.2B
Q2 24
$681.3M
$1.4B
Q1 24
$628.6M
$1.3B
Net Profit
ALHC
ALHC
TEX
TEX
Q4 25
$-11.0M
$63.0M
Q3 25
$3.7M
$65.0M
Q2 25
$15.7M
$72.0M
Q1 25
$-9.1M
$21.0M
Q4 24
$-31.1M
$-2.2M
Q3 24
$-26.4M
$88.0M
Q2 24
$-24.0M
$140.7M
Q1 24
$-46.5M
$108.5M
Gross Margin
ALHC
ALHC
TEX
TEX
Q4 25
18.8%
Q3 25
20.3%
Q2 25
19.6%
Q1 25
18.7%
Q4 24
15.9%
Q3 24
20.2%
Q2 24
23.8%
Q1 24
23.0%
Operating Margin
ALHC
ALHC
TEX
TEX
Q4 25
-1.0%
10.4%
Q3 25
0.8%
10.1%
Q2 25
2.2%
8.7%
Q1 25
-0.6%
5.6%
Q4 24
-3.2%
4.2%
Q3 24
-2.8%
10.1%
Q2 24
-2.7%
14.0%
Q1 24
-6.5%
12.2%
Net Margin
ALHC
ALHC
TEX
TEX
Q4 25
-1.1%
4.8%
Q3 25
0.4%
4.7%
Q2 25
1.5%
4.8%
Q1 25
-1.0%
1.7%
Q4 24
-4.4%
-0.2%
Q3 24
-3.8%
7.3%
Q2 24
-3.5%
10.2%
Q1 24
-7.4%
8.4%
EPS (diluted)
ALHC
ALHC
TEX
TEX
Q4 25
$-0.04
$0.95
Q3 25
$0.02
$0.98
Q2 25
$0.07
$1.09
Q1 25
$-0.05
$0.31
Q4 24
$-0.15
$-0.03
Q3 24
$-0.14
$1.31
Q2 24
$-0.13
$2.08
Q1 24
$-0.25
$1.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
TEX
TEX
Cash + ST InvestmentsLiquidity on hand
$604.2M
$772.0M
Total DebtLower is stronger
$323.2M
$2.6B
Stockholders' EquityBook value
$179.3M
$2.1B
Total Assets
$1.1B
$6.1B
Debt / EquityLower = less leverage
1.80×
1.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
TEX
TEX
Q4 25
$604.2M
$772.0M
Q3 25
$644.1M
$509.0M
Q2 25
$503.8M
$374.0M
Q1 25
$479.5M
$298.0M
Q4 24
$470.6M
$388.0M
Q3 24
$381.0M
$352.0M
Q2 24
$363.7M
$319.3M
Q1 24
$301.7M
$364.9M
Total Debt
ALHC
ALHC
TEX
TEX
Q4 25
$323.2M
$2.6B
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
$2.6B
Q3 24
$212.0M
Q2 24
$211.7M
Q1 24
$162.0M
Stockholders' Equity
ALHC
ALHC
TEX
TEX
Q4 25
$179.3M
$2.1B
Q3 25
$161.9M
$2.0B
Q2 25
$141.0M
$2.0B
Q1 25
$108.1M
$1.8B
Q4 24
$99.9M
$1.8B
Q3 24
$114.5M
$2.0B
Q2 24
$123.7M
$1.8B
Q1 24
$130.9M
$1.7B
Total Assets
ALHC
ALHC
TEX
TEX
Q4 25
$1.1B
$6.1B
Q3 25
$1.1B
$6.2B
Q2 25
$1.0B
$6.2B
Q1 25
$895.6M
$5.8B
Q4 24
$782.1M
$5.7B
Q3 24
$692.3M
$3.8B
Q2 24
$716.3M
$3.8B
Q1 24
$633.2M
$3.8B
Debt / Equity
ALHC
ALHC
TEX
TEX
Q4 25
1.80×
1.23×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
1.41×
Q3 24
1.85×
Q2 24
1.71×
Q1 24
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
TEX
TEX
Operating Cash FlowLast quarter
$-50.4M
$205.0M
Free Cash FlowOCF − Capex
$-55.4M
$171.0M
FCF MarginFCF / Revenue
-5.5%
13.0%
Capex IntensityCapex / Revenue
0.5%
2.6%
Cash ConversionOCF / Net Profit
3.25×
TTM Free Cash FlowTrailing 4 quarters
$113.1M
$322.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
TEX
TEX
Q4 25
$-50.4M
$205.0M
Q3 25
$144.6M
$154.0M
Q2 25
$29.1M
$102.0M
Q1 25
$16.6M
$-21.0M
Q4 24
$-8.7M
$177.0M
Q3 24
$26.2M
$116.4M
Q2 24
$23.5M
$66.5M
Q1 24
$-6.2M
$-33.9M
Free Cash Flow
ALHC
ALHC
TEX
TEX
Q4 25
$-55.4M
$171.0M
Q3 25
$139.1M
$130.0M
Q2 25
$21.1M
$78.0M
Q1 25
$8.4M
$-57.0M
Q4 24
$-18.0M
$128.0M
Q3 24
$16.9M
$87.4M
Q2 24
$11.8M
$42.5M
Q1 24
$-17.4M
$-68.9M
FCF Margin
ALHC
ALHC
TEX
TEX
Q4 25
-5.5%
13.0%
Q3 25
14.0%
9.4%
Q2 25
2.1%
5.2%
Q1 25
0.9%
-4.6%
Q4 24
-2.6%
10.3%
Q3 24
2.4%
7.2%
Q2 24
1.7%
3.1%
Q1 24
-2.8%
-5.3%
Capex Intensity
ALHC
ALHC
TEX
TEX
Q4 25
0.5%
2.6%
Q3 25
0.6%
1.7%
Q2 25
0.8%
1.6%
Q1 25
0.9%
2.9%
Q4 24
1.3%
3.9%
Q3 24
1.3%
2.4%
Q2 24
1.7%
1.7%
Q1 24
1.8%
2.7%
Cash Conversion
ALHC
ALHC
TEX
TEX
Q4 25
3.25×
Q3 25
38.77×
2.37×
Q2 25
1.86×
1.42×
Q1 25
-1.00×
Q4 24
Q3 24
1.32×
Q2 24
0.47×
Q1 24
-0.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

TEX
TEX

Aerials Segment$466.0M35%
Materials Processing Segment$428.0M32%
Materials Processing Equipment$279.0M21%
Specialty Equipment$148.0M11%

Related Comparisons